Dopamine transporter single-photon emission (DaT-Scan), despite being a modality that mainly aims to detect dopaminergic deficit in patients with Parkinson’s disease (PD) and atypical parkinsonian syndromes, has also been found to be impaired in iNPH patients by a few studies [57,58]. This evidence concerns the gene SLC6A3 and Parkinson disease.